• 5733 Citations
  • 33 h-Index
1993 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where B. Hilda Ye is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Germinal Center Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Zinc Fingers Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Genes Medicine & Life Sciences
Proto-Oncogene Proteins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2000 2012

Proto-Oncogenes
B-Cell Lymphoma
B-Lymphocytes
Germinal Center
Co-Repressor Proteins

Publications 1993 2019

  • 5733 Citations
  • 33 h-Index
  • 55 Article

High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma–implications for staging

Acuna-Villaorduna, A., Gonzalez-Lugo, J., Ye, B. H., Adrianzen Herrera, D. A., Sica, R. A., Shah, U., Shah, N., Kornblum, N., Braunschweig, I., Derman, O., Mantzaris, I., Shastri, A., Wang, Y., Verma, A. K., Zalta, A. B. & Janakiram, M., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Adult T Cell Leukemia Lymphoma
Human T-lymphotropic virus 1
Tomography
Lung
Thorax
1 Citation (Scopus)

PAK kinase inhibition has therapeutic activity in novel preclinical models of adult T-Cell leukemia/lymphoma

Chung, E. Y. L., Mai, Y., Shah, U. A., Wei, Y., Ishida, E., Kataoka, K., Ren, X., Pradhan, K., Bartholdy, B. A., Wei, X., Zou, Y., Zhang, J., Ogawa, S., Steidl, U. G., Zang, X., Verma, A. K., Janakiram, M. & Ye, B. H., Jun 15 2019, In : Clinical Cancer Research. 25, 12, p. 3589-3601 13 p.

Research output: Contribution to journalArticle

p21-Activated Kinases
Adult T Cell Leukemia Lymphoma
Therapeutics
Cell Survival
Protein Isoforms

The ETS inhibitors YK-4-279 and TK-216 are novel antilymphoma agents

Spriano, F., Chung, E. Y. L., Gaudio, E., Tarantelli, C., Cascione, L., Napoli, S., Jessen, K., Carrassa, L., Priebe, V., Sartori, G., Graham, G., Selvanathan, S. P., Cavalli, A., Rinaldi, A., Kwee, I., Testoni, M., Genini, D., Ye, B. H., Zucca, E., Stathis, A. & 3 others, Lannutti, B., Toretsky, J. A. & Bertoni, F., Aug 15 2019, In : Clinical Cancer Research. 25, 16, p. 5167-5176 10 p.

Research output: Contribution to journalArticle

Lymphoma
Transcription Factors
RNA Helicases
Cell Line
Germinal Center
8 Citations (Scopus)

North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies

Shah, U. A., Chung, E. Y. L., Giricz, O., Pradhan, K., Kataoka, K., Gordon-Mitchel, S., Bhagat, T. D., Mai, Y., Wei, Y., Ishida, E., Choudhary, G. S., Joseph, A., Rice, R., Gitego, N., Parrish, C., Bartenstein, M., Goel, S., Mantzaris, I., Shastri, A., Derman, O. & 13 others, Binder, A., Gritsman, K., Kornblum, N., Braunschweig, I., Bhagat, C., Hall, J., Graber, A., Ratner, L., Wang, Y., Ogawa, S., Verma, A. K., Ye, B. H. & Janakiram, M., Oct 4 2018, In : Blood. 132, 14, p. 1507-1518 12 p.

Research output: Contribution to journalArticle

Adult T Cell Leukemia Lymphoma
T-cells
Epigenomics
decitabine
Mutation Rate
7 Citations (Scopus)

Sox11 augments bcr signaling to drive mcl-like tumor development

Kuo, P. Y., Jatiani, S. S., Rahman, A. H., Edwards, D., Jiang, Z., Ahr, K., Perumal, D., Leshchenko, V. V., Brody, J., Shaknovich, R., Ye, B. H. & Parekh, S., May 17 2018, In : Blood. 131, 20, p. 2247-2255 9 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Tumors
B-Lymphocytes
Cells
Neoplasms